PGC Human

Progastricsin-C Human Recombinant
Shipped with Ice Packs
In Stock

Description

Clinical Relevance of PGC

Biomarker for Gastric Diseases:

  • Serum PGC levels correlate with Helicobacter pylori infections, chronic gastritis, and gastric cancer risk .

  • Polymorphisms in the PGC gene are linked to susceptibility to duodenal ulcers and gastric adenocarcinoma .

Diagnostic Utility:

ConditionAssociation with PGCReferences
H. pylori gastritisElevated PGC levels in serum
Gastric cancerGenetic variants increase risk
Duodenal ulcerPolymorphisms alter enzyme activity

PGC in Developmental Biology: Primordial Germ Cells (PGCs)

Human primordial germ cells (PGCs) are the earliest precursors of gametes, specified during weeks 2–3 of embryonic development. Key findings include:

Specification Mechanisms:

  • PGCs arise from TFAP2A+ progenitors at the posterior embryonic disc, sharing transcriptional similarities with amnion cells .

  • Critical regulators: SOX17, PRDM1, and TFAP2C drive PGC commitment, differing from mouse models .

In Vitro Models:

  • Human pluripotent stem cells (PSCs) differentiate into PGC-like cells (PGCLCs) using BMP4 and other cytokines .

  • PGCLCs exhibit migratory behavior via CXCR4/CXCL12 signaling, mimicking embryonic PGCs .

Implications for Medicine:

  • PGCLC models aid in studying infertility and germ cell tumors .

  • Potential for generating functional gametes for reproductive therapies .

Research Milestones

Key Studies:

  1. PGCLC Differentiation (2015): Irie et al. established a serum-free protocol to generate PGCLCs from PSCs, identifying SOX17 as a human-specific PGC marker .

  2. Epigenetic Reprogramming (2023): TFAP2A was identified as essential for PGC specification, linking amnion and germline origins .

  3. Clinical Biomarkers (2023): Cross-disorder meta-analyses validated PGC’s role in gastric disease diagnostics .

Challenges and Future Directions

  • Technical Limitations: Low efficiency in PGCLC differentiation and variability across cell lines .

  • Ethical Considerations: Use of human embryonic material remains restricted, necessitating robust in vitro models .

  • Therapeutic Goals: Optimize protocols for generating functional gametes and targeting PGC-related cancers .

Product Specs

Introduction
Progastricsin-C (PGC) is an aspartic proteinase synthesized in the gastric mucosa as inactive precursors. Belonging to the peptidase family A1, PGC contains a prosegment that stabilizes its inactive form and blocks substrate entry to the active site. PGC serves as a biomarker for various gastric diseases, including Helicobacter pylori related gastritis, and plays a role in hydrolyzing various proteins.
Description
Produced in Sf9 Baculovirus cells, PGC is a single, glycosylated polypeptide chain consisting of 380 amino acids (17-388 a.a.) with a molecular mass of 41.6kDa. On SDS-PAGE, its molecular size appears approximately between 40-57kDa. PGC is expressed with an 8 amino acid His tag at the C-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The PGC protein solution (0.25mg/ml) is supplied in Phosphate Buffered Saline (pH 7.4) with 10% glycerol.
Stability
For short-term storage (2-4 weeks), store at 4°C. For extended periods, store frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 95.0% as determined by SDS-PAGE analysis.
Synonyms
Progastricsin (Pepsinogen C), Pepsinogen C, EC 3.4.23.3, Pepsinogen Group II, Preprogastricsin, EC 3.4.23, Pepsin C, PGII, PEPC.
Source
Sf9, Baculovirus cells.
Amino Acid Sequence
AVVKVPLKKF KSIRETMKEK GLLGEFLRTH KYDPAWKYRF GDLSVTYEPM AYMDAAYFGE ISIGTPPQNF LVLFDTGSSN LWVPSVYCQS QACTSHSRFN PSESSTYSTN GQTFSLQYGS GSLTGFFGYD TLTVQSIQVP NQEFGLSENE PGTNFVYAQF DGIMGLAYPA LSVDEATTAM QGMVQEGALT SPVFSVYLSN QQGSSGGAVV FGGVDSSLYT GQIYWAPVTQ ELYWQIGIEE FLIGGQASGW CSEGCQAIVD TGTSLLTVPQ QYMSALLQAT GAQEDEYGQF LVNCNSIQNL PSLTFIINGV EFPLPPSSYI LSNNGYCTVG VEPTYLSSQN GQPLWILGDV FLRSYYSVYD LGNNRVGFAT AALEHHHHHH.

Q&A

What is the Philippine Genome Center's strategic approach to human genomics research?

The Philippine Genome Center employs a multidisciplinary research strategy centered on the Filipinome Project, which aims to sequence the genomes of thousands of Filipinos representing different regions of the country. This approach establishes baseline information for understanding genetic variations and similarities in Filipino populations . The center's methodology integrates next-generation sequencing technologies with advanced bioinformatics to identify population-specific genetic markers that can inform healthcare decisions.

The strategic framework for 2019-2025 emphasizes three priority areas:

  • Social responsibility - addressing society's needs through personalized and "Filipinized" medicine ("Nararapat na Gamot sa Bawat Filipino")

  • Social entrepreneurship - utilizing genomics knowledge to generate innovative ideas and business models

  • Genomics appreciation - engaging stakeholders from academia, government, private sector, and the public

This methodological approach connects scientists with society by developing solutions in areas of national importance, including health, agriculture, biodiversity, and computational genomics.

How is PGC structured to support interdisciplinary human genomics research?

The Philippine Genome Center implements a program-based organizational structure that facilitates interdisciplinary research across multiple domains of human genomics. The center maintains specialized facilities equipped with state-of-the-art sequencing technologies and bioinformatics resources that make genomic research tools accessible to Filipino scientists .

Key structural elements include:

Program AreaResearch FocusInterdisciplinary Connections
Health GenomicsGenetic factors in disease susceptibility and treatment responseClinical medicine, epidemiology, pharmacology
Computational GenomicsBig data analytics, algorithm developmentComputer science, statistics, systems biology
Biodiversity, Ethnicity & ForensicsPopulation genetics, ancestry studiesAnthropology, ecology, legal sciences
DNA Sequencing Core FacilityMulti-omics data generationServes all research programs with technical support

This structure supports PGC's goal to position itself as an industry leader in big data analytics involving genomics research in the Philippines while ensuring operational efficiency as both a research unit and service provider .

What are the major challenges in establishing population-specific genomic databases for Filipinos?

Establishing population-specific genomic databases for Filipinos presents several methodological challenges that require systematic approaches:

  • Sampling representativeness: The Philippine archipelago comprises over 7,000 islands with 175+ ethnolinguistic groups, necessitating careful sampling strategies to capture this diversity. Researchers must employ geographic stratification and ethnicity-based recruitment to ensure adequate representation of population substructures.

  • Reference genome limitations: Standard reference genomes lack representation of Filipino-specific variants, requiring the development of population-adjusted references that incorporate local genetic diversity .

  • Infrastructural requirements: Managing and analyzing large-scale genomic data demands sophisticated computational infrastructure. PGC addresses this through strategic management objectives that include positioning the center as an industry leader in big data analytics for genomics research .

  • Ethical governance: Balancing open science principles with protection of population genetic data requires specialized frameworks. PGC implements governance structures with multi-sectoral stakeholder engagement to develop appropriate policies.

  • Sustainability challenges: Maintaining and expanding population databases requires continuous resource allocation. PGC explores new business models and maximizes existing ones for resource generation and program continuity .

These challenges are addressed through PGC's strategic plan which emphasizes nationwide expansion, operational efficiency, and financial sustainability to improve accessibility of genomics technology throughout the country .

How does the Filipinome Project implement population genomics methodologies?

The Filipinome Project implements a comprehensive population genomics methodology designed to characterize the genetic landscape of Filipino populations with scientific rigor. The project employs a multi-phase research protocol:

  • Strategic sampling design: Participants are recruited through a geographically stratified approach that ensures proportional representation of major islands and ethnolinguistic groups. This sampling methodology employs both random and targeted recruitment strategies to balance population representation with statistical power.

  • Sequencing strategy: The project utilizes a tiered sequencing approach combining:

    • Whole genome sequencing (30x coverage) for a core reference cohort

    • Whole exome sequencing for broader population sampling

    • Targeted genotyping arrays for large-scale phenotype association studies

  • Bioinformatics pipeline: Custom analysis workflows address the unique characteristics of Filipino genetic data, including:

    • Population-specific variant filtering parameters

    • Local ancestry inference algorithms

    • Identity-by-descent mapping for detecting population substructure

  • Data integration framework: The methodology incorporates multiple data types through a centralized database architecture linking:

Data TypeCollection MethodIntegration Approach
Genomic variantsNGS & genotypingUnified variant calling pipeline
Clinical phenotypesStandardized assessmentsStructured electronic capture
Environmental exposuresGeocoded surveysGIS data correlation
Family relationshipsPedigree documentationNetwork graph modeling

This methodological framework supports PGC's strategic goal of conducting impactful research towards improving the quality of life in the Philippines through genomics .

What experimental approaches are used to analyze Filipino-specific genetic variants?

Analyzing Filipino-specific genetic variants requires specialized experimental approaches that extend beyond standard genomic methodologies. PGC employs a multi-platform research strategy that combines:

  • Variant discovery protocols: Multi-algorithm consensus calling methods detect both common and rare variants, with particular attention to structural variations that may be unique to Filipino populations. This approach utilizes complementary sequencing technologies to overcome technological biases:

    • Short-read sequencing for high-throughput SNP and small indel detection

    • Long-read sequencing to resolve complex structural variants and repetitive regions

    • Array-based methods for validation and large-scale genotyping

  • Functional characterization pipeline: Identified Filipino-specific variants undergo systematic functional assessment through:

    • Computational prediction using multiple in silico tools calibrated with Filipino genetic data

    • Cell-based reporter assays for variants in regulatory regions

    • CRISPR-based genome editing to evaluate phenotypic impact in relevant cell types

  • Population genetics analysis: Specialized statistical methods examine:

    • Selection signatures that may indicate adaptive variants specific to island environments

    • Archaic admixture patterns reflecting historical migration events

    • Haplotype structure analysis revealing population-specific recombination patterns

  • Clinical correlation framework: A structured approach connects genetic findings with health outcomes through:

    • Case-control studies for disease-associated variants

    • Pharmacogenomic analyses for drug response prediction

    • Longitudinal cohort studies tracking genotype-phenotype relationships over time

These methodological approaches align with PGC's mission to develop and expand existing programs to capacitate Filipino researchers in genomic studies while conducting impactful research for national development .

How are computational resources optimized for large-scale genomic data analysis at PGC?

PGC implements a systematic approach to computational resource optimization for large-scale genomic data analysis, addressing both technical efficiency and accessibility for researchers. The methodology encompasses:

  • Infrastructure architecture: A hybrid computing environment balances performance requirements with resource constraints:

    • High-performance computing clusters for computation-intensive analyses

    • Cloud-based solutions for scalable storage and collaborative projects

    • Edge computing deployment for preliminary data processing at collection sites

  • Workflow optimization: Computational efficiency is maximized through:

    • Containerized pipelines ensuring reproducibility and portable deployment

    • Parallel processing frameworks reducing time-to-results for large datasets

    • Incremental analysis strategies that prioritize high-value genomic regions

  • Resource allocation framework: Computing resources are strategically distributed based on project priorities:

Analysis TypeComputing ResourcesOptimization Strategy
Production pipelinesDedicated HPC nodesScheduled batch processing
Method developmentGPU-accelerated systemsInteractive development environments
Training activitiesVirtualized resourcesResource throttling during non-peak hours
Collaborative projectsFederated computingDistributed data processing
  • Sustainability approaches: Long-term viability is ensured through:

    • Energy-efficient computing practices

    • Tiered data archiving policies based on access frequency

    • Strategic partnerships with international computing centers

This computational methodology supports PGC's strategic objective to "ensure operational efficiency as a research unit and service provider" while positioning itself as "an industry leader in big data analytics involving genomics research in the Philippines" .

What methodologies are used to derive and characterize human primordial germ cell-like cells?

Human primordial germ cell-like cells (PGCLCs) are derived and characterized through a rigorous methodological framework that recapitulates key developmental events. The experimental approach includes:

  • Stepwise differentiation protocol: Human pluripotent stem cells undergo directed differentiation through defined stages:

    • Induction of competent epiblast-like cells using activin A and basic FGF

    • Specification toward PGC fate using BMP4, SCF, EGF, and ROCK inhibitor

    • Maturation in suspension culture with specific growth factor combinations

  • Molecular characterization: Comprehensive profiling confirms PGCLC identity through:

    • Transcriptome analysis documenting expression of germ cell markers (OCT4, NANOG, SOX17, BLIMP1)

    • Epigenetic assessment of DNA methylation reprogramming and histone modification patterns

    • Immunofluorescence visualization of lineage-specific protein markers

  • Functional assessment: PGCLCs undergo evaluation of key germline characteristics:

    • Methylation erasure at imprinted loci

    • Reactivation of X chromosome in female cells

    • Analysis of meiotic competence markers

  • Comparative analysis: Human PGCLCs are systematically compared with:

Reference StandardAssessment ParametersAnalytical Methods
Human fetal PGCsTranscriptional profileRNA-seq with principal component analysis
Mouse PGCLCsDevelopmental kineticsTime-course gene expression analysis
In vivo migration patternsChemotactic responsesTransmigration assays

This methodological approach provides researchers with reliable protocols for generating human PGCLCs that faithfully model primordial germ cell development for basic and translational research applications .

What are the key molecular mechanisms governing human primordial germ cell specification?

Human primordial germ cell specification is governed by a complex network of molecular mechanisms that differ significantly from those in model organisms. Current research methodologies have elucidated several key regulatory pathways:

  • Transcriptional regulation: Human PGC specification employs a unique transcription factor cascade:

    • SOX17 functions as the critical specifier, unlike mouse PGCs which depend primarily on Blimp1

    • BLIMP1 acts downstream of SOX17 to repress somatic programs

    • TFAP2C collaborates with these factors to establish and maintain germ cell identity

  • Signaling pathway integration: Multiple signaling inputs coordinate to induce germline fate:

    • BMP signaling activation through SMAD1/5/8 phosphorylation initiates the specification process

    • WNT signaling modulates competence of precursor cells

    • Downstream effectors integrate these signals to activate germ cell genes while suppressing somatic differentiation

  • Epigenetic reprogramming: Extensive chromatin remodeling accompanies specification:

    • Global DNA demethylation, including at imprinted loci

    • Histone modification changes, particularly H3K9me2 reduction and H3K27me3 redistribution

    • Chromatin accessibility alterations at germline-specific enhancers

  • Metabolic adaptation: Metabolic reconfigurations support the energy demands and biosynthetic requirements:

    • Mitochondrial dynamics changes

    • Glycolytic pathway modifications

    • Lipid metabolism adjustments

These mechanisms interact through feedback loops and redundant pathways that ensure robust specification despite developmental variability. Understanding these processes through experimental models like in vitro PGCLC differentiation provides valuable insights into human germline development and potential applications in reproductive medicine .

How do in vitro differentiation conditions affect the developmental potential of human PGCLCs?

The developmental potential of human primordial germ cell-like cells (PGCLCs) is significantly influenced by specific in vitro differentiation conditions through multiple mechanistic pathways. Systematic experimental analysis has identified several critical parameters:

  • Temporal factor exposure: The precise timing and duration of morphogen treatment critically affects developmental trajectory:

    • Early BMP4 exposure (day 1-2) promotes mesendoderm formation rather than germline specification

    • Sequential application of WNT activators followed by BMP4 enhances PGCLC induction efficiency

    • Extended culture periods lead to heterogeneous populations with variable developmental potential

  • Substrate and architecture effects: The physical microenvironment modulates cell fate decisions:

    • 2D monolayer cultures support initial specification but limit maturation

    • 3D aggregates (embryoid bodies) better recapitulate the spatial organization of developing tissue

    • Extracellular matrix composition influences adhesion-dependent signaling pathways

  • Metabolic parameters: Bioenergetic conditions significantly impact developmental outcomes:

Metabolic ParameterOptimal RangeEffect on PGCLC Development
Oxygen tension5-7%Enhances specification by activating HIF-dependent pathways
Glucose concentration5.5-10 mMBalances glycolytic flux with pentose phosphate pathway activity
Fatty acid availabilityMedium-dependentInfluences membrane composition and signaling platform formation
  • Starting cell state: The pluripotent stem cell state prior to differentiation significantly impacts outcome:

    • Naive pluripotent cells require different induction protocols than primed cells

    • Epigenetic memory from source cells can influence differentiation bias

    • Genetic background affects response to identical differentiation conditions

These findings emphasize the importance of precisely controlled differentiation protocols with defined parameters to generate PGCLCs with consistent characteristics for research applications. The methodology must account for these variables to ensure reproducibility across different experimental settings and cell lines .

What bioinformatics pipelines are used for analyzing Filipino genomic data?

The Philippine Genome Center employs specialized bioinformatics pipelines optimized for Filipino genomic data that address population-specific analytical challenges. These methodological frameworks include:

  • Variant discovery and annotation pipeline: A customized workflow that integrates:

    • Multiple variant callers (GATK, FreeBayes, DeepVariant) with Filipino-specific filtering parameters

    • Population frequency annotation drawing from internal PGC databases of Filipino variants

    • Functional prediction algorithms recalibrated with Filipino genetic backgrounds

    • Ancestry-aware variant prioritization incorporating Filipino population substructure

  • Structural variant analysis framework: Specialized methods detect complex genomic rearrangements:

    • Long-read alignment strategies optimized for repetitive regions common in Filipino genomes

    • Integration of complementary detection approaches (read-pair, split-read, depth-based)

    • Validation protocols using orthogonal technologies to confirm novel structural variants

  • Pharmacogenomic analysis workflow: A systematic approach to drug response prediction:

    • Genotype extraction for pharmacogenomically relevant loci

    • Star-allele calling algorithms adapted for Filipino allele frequencies

    • Clinical annotation mapping prioritized for medications commonly used in Filipino healthcare settings

  • Integrative multi-omics platform: A unified framework connecting different data types:

Data LayerAnalytical MethodsIntegration Approach
Genomic variantsPopulation-specific callingShared identifier system
Transcriptome profilesFilipino-specific expression referencesCorrelation network analysis
Epigenomic markersEthnic-adjusted normalizationMulti-modal factor analysis
Clinical phenotypesCulturally-validated measuresMultivariate regression modeling

These bioinformatics pipelines are continuously refined through benchmarking studies and support PGC's strategic objective to "position the PGC as an industry leader in big data analytics involving genomics research in the Philippines" .

How are population-specific reference genomes constructed for Filipino genomics research?

Construction of population-specific reference genomes for Filipino genomics research follows a systematic methodology that addresses the unique genetic diversity of the Filipino population. The process encompasses:

  • Deep sequencing strategy: Selected individuals representing major Filipino ethnolinguistic groups undergo:

    • High-coverage (50-60x) whole genome sequencing using paired-end short reads

    • Long-read sequencing (Oxford Nanopore or PacBio) for complex regions

    • Linked-read technologies to resolve haplotype phases

    • Optical mapping for structural validation

  • Assembly pipeline optimization: Computational approaches tailored for Filipino genetic characteristics:

    • Graph-based assembly methods incorporating known Filipino variants

    • De novo assembly of divergent regions not represented in standard references

    • Iterative refinement through multiple assembly algorithms

    • Gap-filling strategies targeting traditionally difficult regions

  • Comparative validation framework: Multiple quality control procedures ensure reference accuracy:

    • Alignment to standard reference genomes to identify structural differences

    • Validation using orthogonal technologies (array-based genotyping, targeted sequencing)

    • Functional element annotation comparison

    • Variant calling performance evaluation using truth sets

  • Reference panel construction: The final reference resources include:

Reference ComponentConstruction MethodResearch Application
Core Filipino referenceConsensus from diverse samplesPrimary alignment target
Regional-specific alternativesEthnicity-focused assembliesLocal ancestry analysis
Pangenome representationGraph-based integrationComprehensive variant detection
Imputation panelsDense haplotype mapsCost-effective study designs

This methodological approach enables the development of reference resources that better capture Filipino genetic diversity, improving the accuracy of downstream analyses from variant calling to association studies. These efforts align with PGC's goal to "conduct impactful research and scholarly activities towards improving the quality of life in the Philippines" .

What computational methods are used to study cell fate transitions in human PGC development?

Computational analysis of cell fate transitions during human primordial germ cell development employs sophisticated methodologies to decipher complex developmental processes. The analytical framework includes:

  • Single-cell trajectory analysis: Computational methods reconstruct developmental progressions:

    • Dimensionality reduction techniques (t-SNE, UMAP) visualize cell populations in low-dimensional space

    • Pseudotime algorithms (Monocle, RNA velocity) order cells along developmental trajectories

    • Branching point detection identifies critical decision nodes in cell fate specification

    • Differential expression testing along trajectories reveals stage-specific gene programs

  • Gene regulatory network inference: Computational approaches reconstruct regulatory relationships:

    • Co-expression analysis identifies coordinately regulated gene modules

    • Transcription factor binding site enrichment predicts direct regulatory interactions

    • Causal network modeling incorporates temporal information to infer directionality

    • Network perturbation simulations predict master regulators of cell fate transitions

  • Multi-modal data integration: Computational methods connect different molecular layers:

    • Multi-omics factor analysis identifies coordinated changes across data types

    • Transfer learning approaches leverage information across datasets

    • Joint dimensionality reduction techniques create unified representations of cells

  • Comparative developmental analysis: Computational frameworks for cross-species comparison:

Analytical MethodComputational ApproachResearch Application
Ortholog mappingSequence conservation analysisIdentifying evolutionary conserved mechanisms
Temporal alignmentDynamic time warpingComparing developmental timing across species
Network conservationGraph-theoretic comparisonDetecting conserved regulatory circuits
Divergence hotspot identificationStatistical divergence measuresDiscovering human-specific features

These computational methodologies enable researchers to extract mechanistic insights from complex experimental data, identifying key regulatory events and molecular drivers of human PGC specification that may differ from model organisms. The approach combines data-driven discovery with hypothesis testing to advance understanding of human germline development .

How is PGC translating genomic findings into precision medicine applications for Filipinos?

The Philippine Genome Center employs a structured translational framework to convert genomic discoveries into precision medicine applications specifically tailored for Filipino populations. The methodological approach encompasses:

  • Pharmacogenomic implementation pipeline: A systematic process translates genetic variation data into clinical decision support:

    • Identification of Filipino-specific variants affecting drug metabolism and response

    • Development of population-adjusted dosing algorithms for essential medications

    • Clinical validation studies in Filipino healthcare settings

    • Integration with electronic health records through standardized interfaces

  • Disease risk prediction framework: A methodical approach to developing Filipino-specific risk models:

    • Genome-wide association studies identifying risk variants in Filipino populations

    • Integration of polygenic risk scores with traditional clinical risk factors

    • Calibration of prediction models using Filipino population data

    • Validation in prospective Filipino cohorts to assess predictive performance

  • Diagnostic genomics pathway: A structured approach for implementing genomic diagnostics:

    • Development of targeted sequencing panels for conditions prevalent in Filipino populations

    • Establishment of Filipino-specific variant classification frameworks

    • Clinical laboratory validation following international standards

    • Integration with existing healthcare delivery systems

  • Knowledge translation strategy: A comprehensive approach to implementation science:

Translation ComponentMethodological ApproachImplementation Metrics
Clinical guideline developmentEvidence synthesis with Filipino contextAdoption rates in healthcare institutions
Healthcare provider educationSpecialized genomics training programsKnowledge assessment scores
Patient education resourcesCulturally appropriate materialsComprehension and decision satisfaction
Policy engagementStakeholder consensus developmentRegulatory framework adaptation

This translational methodology supports PGC's strategic goal of "Nararapat na Gamot sa Bawat Filipino" (appropriate medicine for every Filipino), ensuring that genomic innovations address the specific needs of Filipino populations while respecting cultural contexts and healthcare system constraints .

What research applications connect the Filipinome Project to public health initiatives?

The Filipinome Project connects to public health initiatives through systematic research applications that translate genomic insights into population health improvements. The methodological framework integrates:

  • Infectious disease genomics: A structured approach to pathogen surveillance and response:

    • Genome-based tracking of pathogen transmission patterns across the Philippine archipelago

    • Identification of genetic factors affecting Filipino susceptibility to endemic infections

    • Pharmacogenomic optimization of antimicrobial treatments for Filipino patients

    • Development of genomics-informed vaccination strategies addressing population-specific immune responses

  • Non-communicable disease prevention: A methodical approach to chronic disease risk reduction:

    • Identification of Filipino-specific genetic risk factors for diabetes, cardiovascular disease, and cancer

    • Development of targeted screening recommendations based on genomic risk stratification

    • Nutritional genomics research exploring diet-gene interactions in Filipino populations

    • Environmental genomics studies examining gene-environment interactions specific to Philippine settings

  • Public health emergency preparedness: Systematic integration of genomics in emergency response:

    • Rapid sequencing capacity for outbreak pathogens (as demonstrated during COVID-19 response)

    • Filipino-specific genetic risk factor analysis for emerging infectious diseases

    • Genomics-informed containment strategies for region-specific transmission patterns

    • Clinical genomics applications for optimizing treatment protocols during public health crises

  • Health system integration: Structured approaches to implementing genomics in healthcare:

Health System ComponentGenomics Integration MethodPublic Health Impact Measure
Primary carePoint-of-care pharmacogenetic testingAdverse drug event reduction
Maternal-child healthCarrier screening for prevalent conditionsBirth defect prevalence
Cancer control programsRisk-stratified screening protocolsStage-at-diagnosis metrics
Infectious disease surveillancePathogen genomic monitoringOutbreak response time

These research applications demonstrate PGC's commitment to "conduct impactful research and scholarly activities towards improving the quality of life in the Philippines" by ensuring that genomic advances translate into tangible public health benefits for Filipino populations .

How are findings from human PGC research contributing to reproductive medicine advances?

Research on human primordial germ cells (PGCs) contributes to reproductive medicine advances through multiple translational pathways that connect basic developmental biology to clinical applications. The methodological framework includes:

  • Fertility preservation innovation: Insights from PGC development inform novel approaches:

    • In vitro gametogenesis research exploring derivation of functional gametes from pluripotent stem cells

    • Optimization of cryopreservation protocols based on PGC molecular characteristics

    • Development of artificial germline niches that support PGC survival and maturation

    • Identification of molecular markers predicting successful germ cell derivation

  • Reproductive disorder mechanisms: Systematic approaches to understanding pathological processes:

    • Modeling genetic causes of infertility using patient-derived iPSCs differentiated to PGCLCs

    • Investigation of epigenetic dysregulation in germ cell development disorders

    • Toxicological screening to identify environmental compounds disrupting PGC specification

    • Comparative analysis of normal versus abnormal PGC development trajectories

  • Diagnostic advancement: Translation of molecular insights to clinical testing:

    • Development of biomarkers for early detection of germline disorders

    • Non-invasive techniques for assessing reproductive potential

    • Predictive models for reproductive outcomes based on molecular signatures

    • Personalized fertility risk assessment incorporating genetic factors

  • Therapeutic target identification: Systematic approaches to intervention development:

Therapeutic ApproachMethodological StrategyClinical Application Potential
Small molecule screeningPGC differentiation assaysFertility enhancement compounds
Gene therapy targetsFunctional genomics in PGCLCsCorrection of genetic infertility
Supportive factorsGrowth factor optimizationImproved assisted reproduction
Tissue engineeringPGC niche recapitulationArtificial gonad construction

These research applications demonstrate how fundamental studies of human PGC biology can address significant clinical challenges in reproductive medicine, providing new approaches to diagnosis, prevention, and treatment of infertility and related disorders .

What ethical frameworks guide genomic research on Filipino populations?

Genomic research on Filipino populations operates within specialized ethical frameworks that address unique cultural, historical, and social considerations. The methodological approach to ethics encompasses:

  • Cultural competence methodology: Research protocols incorporate Filipino cultural perspectives through:

    • Engagement with community elders and leaders prior to initiating research

    • Recognition of collective decision-making processes in certain communities

    • Incorporation of Filipino values and worldviews in consent processes

    • Acknowledgment of historical contexts affecting trust in research institutions

  • Justice-centered research design: Systematic approaches ensure equitable research practices:

    • Inclusive sampling strategies representing diverse Filipino ethnolinguistic groups

    • Fair benefit-sharing arrangements ensuring research outcomes benefit participating communities

    • Capacity building components that transfer knowledge and skills to Filipino institutions

    • Attention to health priorities relevant to Filipino populations

  • Governance structures: Formalized oversight mechanisms include:

    • Ethics review committees with expertise in genomics and Filipino cultural contexts

    • Community advisory boards providing ongoing input throughout research lifecycle

    • Data access committees with diverse stakeholder representation

    • Transparent processes for handling incidental findings and return of results

  • Informed consent adaptation: Specialized approaches to meaningful consent:

Consent ElementFilipino-Specific AdaptationImplementation Methodology
Language accessibilityTranslation into major Filipino languagesBack-translation verification
Cultural framingIncorporation of Filipino kinship conceptsCommunity consultation
Educational componentsVisual aids addressing varied literacy levelsComprehension assessment
Dynamic consentOptions reflecting Filipino decision preferencesTechnology-supported platforms

These ethical frameworks align with PGC's strategic goal of social responsibility, ensuring that genomics research responds to society's needs while respecting the rights and cultural identities of Filipino participants .

How are data privacy and security maintained in large-scale genomic projects?

Maintaining data privacy and security in large-scale genomic projects at the Philippine Genome Center involves comprehensive methodological approaches that address the sensitive nature of human genetic information. The security framework encompasses:

  • Technical infrastructure: A layered security architecture protects genomic data:

    • Physical security controls restricting access to sequencing and computing facilities

    • Network segmentation isolating genomic data processing environments

    • Encryption protocols for data at rest and in transit

    • Access control mechanisms implementing principle of least privilege

    • Audit logging systems tracking all data access and usage

  • Procedural safeguards: Operational processes reinforce technical measures:

    • Data classification frameworks identifying sensitivity levels of different genomic datasets

    • De-identification protocols removing direct identifiers while maintaining research utility

    • Data access procedures requiring formal applications and approval workflows

    • Data use agreements specifying permissible uses and prohibiting re-identification attempts

    • Regular security assessments and penetration testing of systems

  • Regulatory compliance: Methodical approaches to meeting legal requirements:

    • Alignment with Philippine Data Privacy Act provisions

    • Harmonization with international standards and best practices

    • Regular compliance audits and documentation

    • Incident response protocols for potential data breaches

  • Risk-based security approach: Calibrated protection based on systematic risk assessment:

This comprehensive approach supports PGC's strategic objective to "ensure operational efficiency as a research unit and service provider" while maintaining ethical standards and public trust in genomic research .

What ethical considerations guide research on human germline development?

Research on human germline development operates within specialized ethical frameworks that address the unique considerations of studying cells with reproductive potential. The methodological approach to ethics in this domain encompasses:

  • Regulatory compliance methodology: Research protocols adhere to established guidelines through:

    • Alignment with International Society for Stem Cell Research (ISSCR) recommendations

    • Compliance with national regulations governing human embryo and germline research

    • Regular protocol reviews by specialized oversight committees

    • Clear documentation of ethical compliance throughout research lifecycle

  • Boundaries framework: Research proceeds within defined ethical boundaries:

    • Prohibition of reproductive applications of in vitro derived germ cells

    • Time limitations on culture of human embryo models

    • Restrictions on genetic modification of cells with germline potential

    • Clear separation between permitted research and prohibited applications

  • Source material ethics: Systematic approaches to ethical procurement:

    • Comprehensive informed consent specifically addressing germline research

    • Donor screening protocols balancing scientific needs with donor well-being

    • Transparent compensation policies preventing undue inducement

    • Documentation of provenance throughout cell lineage derivation

  • Anticipatory governance: Forward-looking approaches to emerging ethical challenges:

Ethical ConsiderationMethodological ApproachImplementation Strategy
Scientific justificationResearch necessity assessmentAlternative methods evaluation
Risk-benefit analysisStructured review frameworkMulti-stakeholder evaluation
Societal implicationsEarly engagement with ethical issuesInterdisciplinary discussion forums
Technological advancementHorizon scanning for ethical challengesPolicy development workshops

These ethical frameworks ensure that research on human germline development, including primordial germ cell studies, proceeds responsibly with appropriate oversight and consideration of societal values .

Product Science Overview

Structure and Synthesis

Progastricsin-C is composed of 374 amino acid residues, which include a gastricsin moiety of 331 residues and an activation segment of 43 residues . The gene encoding human PGC is located on chromosome 6, while the human pepsinogen genetic locus is polymorphic and codes for at least three distinct polypeptide sequences on chromosome 11 . The crystal structure of human PGC reveals a bilobal structure with a large active-site cleft between the lobes, where two aspartate residues (Asp32 and Asp215) function as catalytic residues .

Function and Activation

Progastricsin-C is secreted into the gastric lumen, where it is converted into its active form, pepsin C, under acidic conditions . This active enzyme is a major component of the gastric fluid and is responsible for the proteolytic digestion of dietary proteins . In addition to its digestive role, PGC is also present in seminal plasma, where it exhibits aspartyl proteinase-like activity and contributes to the production of pro-antimicrobial substances .

Clinical Significance

Progastricsin-C has been studied extensively for its potential role in various diseases, particularly cancer. The expression of PGC is significantly decreased in the progression from superficial gastritis to atrophic gastritis and eventually to gastric cancer . This makes PGC a valuable negative marker for gastric cancer. Additionally, ectopic expression of PGC has been observed in prostate, breast, ovarian, and endometrial cancers, where high levels of PGC expression are associated with better prognosis and longer survival .

Recombinant Progastricsin-C

Recombinant Progastricsin-C is produced using recombinant DNA technology, which involves inserting the gene encoding PGC into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities. This recombinant form is used in various research and clinical applications, including studies on its structure, function, and potential therapeutic uses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.